Respiratory rhythm generation: triple oscillator hypothesis.
Anderson TM, Ramirez JM.
F1000Res. 2017 Feb 14;6:139. doi: 10.12688/f1000research.10193.1. eCollection 2017.
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Sibbing D, Siontis GCM; ESC Scientific Document Group.
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-kappaB signaling through suppression of NFKBIA transcription.
Yang W, Li J, Zhang M, Yu H, Zhuang Y, Zhao L, Ren L, Gong J, Bi H, Zeng L, Xue Y, Yang J, Zhao Y, Wang S, Gao S, Fu Z, Li D, Zhang J, Wang T, Shan M, Tang B, Li X.
J Exp Clin Cancer Res. 2022 Feb 18;41(1):67. doi: 10.1186/s13046-022-02260-1.
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.
Jakubowska A, Roux CWL, Viljoen A.
Endocrinol Metab (Seoul). 2024 Feb;39(1):12-22. doi: 10.3803/EnM.2024.1942. Epub 2024 Feb 14.
TRIPLE HEART RHYTHM.
Evans W.
Br Heart J. 1943 Oct;5(4):205-28. doi: 10.1136/hrt.5.4.205.
Newer pharmacological interventions directed at gut hormones for obesity.
Camilleri M, Acosta A.
Br J Pharmacol. 2024 Apr;181(8):1153-1164. doi: 10.1111/bph.16278. Epub 2023 Nov 30.
Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis.
Zafeiropoulos S, Farmakis IT, Milioglou I, Doundoulakis I, Gorodeski EZ, Konstantinides SV, Cooper L, Zanos S, Stavrakis S, Giamouzis G, Butler J, Giannakoulas G.
JACC Heart Fail. 2024 Apr;12(4):616-627. doi: 10.1016/j.jchf.2023.07.014. Epub 2023 Aug 30.
[Triple rhythm].
ZUCKERMANN R.
Z Kreislaufforsch. 1961 Feb;50:176-92.
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Ciriello GD, Colonna D, Papaccioli G, Correra A, Romeo E, Palladino MT, Cioppa ND, Russo MG, Sarubbi B.
Pediatr Cardiol. 2023 Jun;44(5):1040-1049. doi: 10.1007/s00246-023-03162-5. Epub 2023 Apr 24.
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review.
Alfaris N, Waldrop S, Johnson V, Boaventura B, Kendrick K, Stanford FC.
EClinicalMedicine. 2024 Aug 30;75:102782. doi: 10.1016/j.eclinm.2024.102782. eCollection 2024 Sep.
